Covalent modalities: covalent drugs  19/03/2024

After a first successful edition dedicated to covalent probes, this edition will focus on the medicinal chemistry aspects of using covalent modalities in the context of drug discovery, with practical examples in oncology and infectious, autoimmunity field by 2 world experts.

  • Organizer : SCT
  • Scientific Commitee : Rebecca Deprez-Poulain (SCT & Univ and Pasteur Institute of Lille)

Enseignement et innovations pédagogiques en chimie organique et médicinale   27/06/2023

Joined webinar dedicaded to teaching medicinal chemistry/organic chemistry and pedagogical innovations, to foster training of future researchers in the field in Master, PhD and comfort the place of chemistry in Pharmacy studies. (in French)

  • OrganizerSCT
  • Co-OrganizersAFECTAECOP
  • Scientific Committee: Line Bourel (AFECT), Christian Cavé (AECOP), Rebecca Deprez-Poulain (SCT)

Covalent modalities: covalent molecular probes  21/11/2022

The aim of the webinar is to offer an introduction to the recent developments of covalent, activity-based probes and reactive warheads, as well as their use in the search for new ligands for potentially hard-to-drug or “undruggable” targets. The webinar will provide a topical overview of this fast-developing field and its potential impact in modern drug development strategies. 

  • Organizer: SCT
  • Scientific Committee: Boris Vauzeilles (SCT & ICSN)
  • Sponsors: EDELRIS  and COVANT

Enseignement et innovations pédagogiques en chimie organique et médicinale  30/06/2022

Joined webinar dedicaded to teachning medicinal chemistry/organic chemistry and pedagogical innovations, to foster training of future researchers in the field in Master, PhD and comfort the place of chemistry in Pharmacy studies. (in French)

  • OrganizerSCT
  • Co-Organizers: AFECT & AECOP
  • Scientific Committee: Line Bourel (AFECT), Nicolas Willand (AECOP), Rebecca Deprez-Poulain (SCT).

Nucleos(t)ides as antiviral drugs : past, present and future  06/04/2022

The aim of the webinar is to present the most recent advances on Nucleoside-Derived Antiviral Drugs from currently contributing investigators. Providing an overview of this important class of Antivirals according to their biological target and mode of action, a perspective on the most salient milestones in drug discovery to meet antiviral medical needs, and current examples of hit identification - lead optimization in antiviral drugs.

  • Organizer: Société de Chimie Thérapeutique
  • Scientific Committee: Maria Duca (SCT) & Olivier Lavergne (SCT)
  • Sponsor: Oxeltis

SCT-ELF Joint Webinar  28/06/2021

Coorganised between European Lead Factory  (ELF) and the Société de Chimie Thérapeutique SCT, this webinar is fully  dedicated  to the French drug discovery community. ELF, a collaborative public private partnership project supported by IMI (Innovative Medicine Initiative) 1 (FP7) & 2 (Horizon 2020), is aiming to deliver  high quality starting points for your Drug Discovery program.

The webinar wishes to present to colleagues from academic research groups and biotech companies in the field of Drug Discovery how ELF can boost their activities in DD in a win-win situation. Open interactive discussions with experts and testimonies will follow after the presentation.

  • OrganizerSociété de Chimie Thérapeutique
  • Co-OrganizerEuropean Lead Factory
  • Scientific Committee:  Brigitte Lesur (Servier & SCT), Rebecca Deprez-Poulain (SCT & Université de Lille, Institut Pasteur de Lille), Daniela Bonora (Lygature), Vera Nies (Lygature).